RAC 2.20% $1.78 race oncology ltd

The RAC 3-Pillar Trifecta, page-190

  1. 642 Posts.
    lightbulb Created with Sketch. 149
    Hi @wombat777, once again thanks for your R&A. I'm just trying to understand your numbers. Can you please clarify some of your assumptions for me?
    -5% share of treatment
    -Pricing Based on average USD $333k for midpoint 900 patients against revenue USD $300M,
    Are you saying our revenue or profit is 5% of the treatment revenue shared with a partner co?
    Are you assuming 900 patients as a market penetration of the 3933 new cases each year?

    Many thanks
    Easysell
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.